EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...

EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced ...

Stephen J. Walker, PhD, and Heather Florio, CEO, unpack the misdiagnosis of urinary tract infections and antibiotic overuse.

Confirmed responses deepened with an average maximum tumor reduction from baseline of 89% and median time on treatment ...

This is one of several subjects for which researchers from Georgia Tech’s School of Interactive Computing earned awards at ...

In most cases, local reports have attributed the attacks to “unidentified gunmen” or described them as occurring under ...

Ukraine impeachment and China election meddling cases are at top of list for review after DNI declassifications revealed ...

Podcaster Joe Rogan joined President Trump and others in the Oval Office on Saturday as he signed an executive order ...

As of Tuesday, April 07, Mesoblast Limited’s MESO share price has dipped by 6.15%, which has investors questioning if this is ...

The FDA has granted Fast Track designation to KT-621, a first-in-class oral STAT6 degrader for moderate to severe ...

The post 'Built on Fear': OpenAI Slams Anthropic’s Safety Culture in Private Memo appeared first on Android Headlines.

Gary Player said he doesn't blame Tiger Woods for taking pain medicine but believes he shouldn't drive a car while on ...